275 related articles for article (PubMed ID: 11331365)
1. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
[TBL] [Abstract][Full Text] [Related]
2. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.
Wick W; Platten M; Weller M
J Neurooncol; 2001 Jun; 53(2):177-85. PubMed ID: 11716069
[TBL] [Abstract][Full Text] [Related]
3. BCL-2-induced glioma cell invasiveness depends on furin-like proteases.
Wick W; Wild-Bode C; Frank B; Weller M
J Neurochem; 2004 Dec; 91(6):1275-83. PubMed ID: 15584904
[TBL] [Abstract][Full Text] [Related]
4. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
Weiler M; Bähr O; Hohlweg U; Naumann U; Rieger J; Huang H; Tabatabai G; Krell HW; Ohgaki H; Weller M; Wick W
Cell Death Differ; 2006 Jul; 13(7):1156-69. PubMed ID: 16254573
[TBL] [Abstract][Full Text] [Related]
5. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
6. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.
Ahmed MM; Alcock RA; Chendil D; Dey S; Das A; Venkatasubbarao K; Mohiuddin M; Sun L; Strodel WE; Freeman JW
J Biol Chem; 2002 Jan; 277(3):2234-46. PubMed ID: 11694525
[TBL] [Abstract][Full Text] [Related]
7. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
Xiao M; Oppenlander BK; Dooley DC
Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
[TBL] [Abstract][Full Text] [Related]
9. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of glioma cell migration and invasion.
Wild-Bode C; Weller M; Wick W
J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
[TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
12. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
13. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.
Roth W; Wild-Bode C; Platten M; Grimmel C; Melkonyan HS; Dichgans J; Weller M
Oncogene; 2000 Aug; 19(37):4210-20. PubMed ID: 10980594
[TBL] [Abstract][Full Text] [Related]
14. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
15. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.
Francis JM; Heyworth CM; Spooncer E; Pierce A; Dexter TM; Whetton AD
J Biol Chem; 2000 Dec; 275(50):39137-45. PubMed ID: 10993901
[TBL] [Abstract][Full Text] [Related]
18. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines.
Pohl U; Wick W; Weissenberger J; Steinbach JP; Dichgans J; Aguzzi A; Weller M
Int J Oncol; 1999 Oct; 15(4):829-34. PubMed ID: 10493969
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]